Kim Leitzel
- Oncology top 2%
- Radiology, Nuclear Medicine and Imaging top 2%
- Molecular Biology
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Allan LiptonSuhail M. AliWalter P. CarneyLaurence M. DemersA. LiptonL. DemersHarold A. HarveyRainer Neumann
- Topics
- HER2/EGFR in Cancer Research (17 papers)Monoclonal and Polyclonal Antibodies Research (12 papers)Cancer Treatment and Pharmacology (8 papers)
- Partner nations
- United StatesUnited KingdomAustria
In The Last Decade
Kim Leitzel
34 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 78
- Oncology 1.3k
- Radiology, Nuclear Medicine and Imaging 743
- Molecular Biology 623
- Cancer Research 330
- Pulmonary and Respiratory Medicine 219
Countries citing papers authored by Kim Leitzel
This map shows the geographic impact of Kim Leitzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Leitzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Leitzel more than expected).
Fields of papers citing papers by Kim Leitzel
This network shows the impact of papers produced by Kim Leitzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Leitzel. The network helps show where Kim Leitzel may publish in the future.
Co-authorship network of co-authors of Kim Leitzel
This figure shows the co-authorship network connecting the top 25 collaborators of Kim Leitzel. A scholar is included among the top collaborators of Kim Leitzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Leitzel. Kim Leitzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 44 | |
| 2 | 11 | |
| 3 | 13 | |
| 4 | 30 | |
| 5 | 171 | |
| 6 | 19 | |
| 7 | 24 | |
| 8 | 69 | |
| 9 | 48 | |
| 10 | 12 | |
| 11 | 40 | |
| 12 | 33 | |
| 13 | 81 | |
| 14 | 61 | |
| 15 | 50 | |
| 16 | 102 | |
| 17 | Serum osteoprotegerin levels in healthy controls and cancer patients. | 108 |
| 18 | Serum HER-2/neu and response to the aromatase inhibitor letrozole versus tamoxifen | 18 |
| 19 | 247 | |
| 20 | 110 |
About Kim Leitzel
Kim Leitzel is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 35 papers that have together received 1.6k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (17 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Cancer Treatment and Pharmacology (8 papers). The work is most often cited by research in Oncology (1.3k citations), Radiology, Nuclear Medicine and Imaging (743 citations) and Cancer Research (330 citations). Kim Leitzel has collaborated with scholars based in United States, United Kingdom and Austria. Frequent co-authors include Allan Lipton, Suhail M. Ali, Walter P. Carney, Laurence M. Demers, A. Lipton, L. Demers, Harold A. Harvey, Rainer Neumann, H Harvey and Y A Teramoto. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.